vs

Side-by-side financial comparison of American Homes 4 Rent (AMH) and Sotera Health Co (SHC). Click either name above to swap in a different company.

American Homes 4 Rent is the larger business by last-quarter revenue ($455.0M vs $303.4M, roughly 1.5× Sotera Health Co). American Homes 4 Rent runs the higher net margin — 31.7% vs 11.5%, a 20.2% gap on every dollar of revenue. On growth, Sotera Health Co posted the faster year-over-year revenue change (4.6% vs 4.2%). American Homes 4 Rent produced more free cash flow last quarter ($823.7M vs $52.4M). Over the past eight quarters, Sotera Health Co's revenue compounded faster (10.6% CAGR vs 3.6%).

American Homes 4 Rent, doing business as AMH, is a real estate investment trust based in Las Vegas, Nevada, that invests in single-family rental homes. As of December 31, 2019, the company owned 52,552 homes in 22 states. Its largest concentrations are in Atlanta, Dallas-Fort Worth, and Charlotte, North Carolina.

Sotera Health Co is a global provider of end-to-end medical safety solutions. It offers sterilization services, analytical laboratory testing, and regulatory advisory support for medical device manufacturers, pharmaceutical firms, and food and consumer product companies, helping clients meet industry standards and ensure product safety for end users worldwide.

AMH vs SHC — Head-to-Head

Bigger by revenue
AMH
AMH
1.5× larger
AMH
$455.0M
$303.4M
SHC
Growing faster (revenue YoY)
SHC
SHC
+0.3% gap
SHC
4.6%
4.2%
AMH
Higher net margin
AMH
AMH
20.2% more per $
AMH
31.7%
11.5%
SHC
More free cash flow
AMH
AMH
$771.3M more FCF
AMH
$823.7M
$52.4M
SHC
Faster 2-yr revenue CAGR
SHC
SHC
Annualised
SHC
10.6%
3.6%
AMH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AMH
AMH
SHC
SHC
Revenue
$455.0M
$303.4M
Net Profit
$144.3M
$34.8M
Gross Margin
54.7%
Operating Margin
23.2%
Net Margin
31.7%
11.5%
Revenue YoY
4.2%
4.6%
Net Profit YoY
0.3%
182.8%
EPS (diluted)
$0.33
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMH
AMH
SHC
SHC
Q4 25
$455.0M
$303.4M
Q3 25
$478.5M
$311.3M
Q2 25
$457.5M
$294.3M
Q1 25
$459.3M
$254.5M
Q4 24
$436.6M
$290.2M
Q3 24
$445.1M
$285.5M
Q2 24
$423.5M
$276.6M
Q1 24
$423.6M
$248.2M
Net Profit
AMH
AMH
SHC
SHC
Q4 25
$144.3M
$34.8M
Q3 25
$116.8M
$48.4M
Q2 25
$123.6M
$8.0M
Q1 25
$128.7M
$-13.3M
Q4 24
$143.9M
$12.3M
Q3 24
$87.6M
$17.0M
Q2 24
$108.5M
$8.8M
Q1 24
$128.1M
$6.3M
Gross Margin
AMH
AMH
SHC
SHC
Q4 25
54.7%
Q3 25
57.0%
Q2 25
56.6%
Q1 25
53.2%
Q4 24
56.6%
Q3 24
55.4%
Q2 24
55.2%
Q1 24
51.2%
Operating Margin
AMH
AMH
SHC
SHC
Q4 25
23.2%
Q3 25
23.4%
Q2 25
6.4%
Q1 25
-5.8%
Q4 24
30.0%
Q3 24
28.2%
Q2 24
27.8%
Q1 24
21.4%
Net Margin
AMH
AMH
SHC
SHC
Q4 25
31.7%
11.5%
Q3 25
24.4%
15.5%
Q2 25
27.0%
2.7%
Q1 25
28.0%
-5.2%
Q4 24
33.0%
4.2%
Q3 24
19.7%
6.0%
Q2 24
25.6%
3.2%
Q1 24
30.2%
2.5%
EPS (diluted)
AMH
AMH
SHC
SHC
Q4 25
$0.33
$0.12
Q3 25
$0.27
$0.17
Q2 25
$0.28
$0.03
Q1 25
$0.30
$-0.05
Q4 24
$0.33
$0.05
Q3 24
$0.20
$0.06
Q2 24
$0.25
$0.03
Q1 24
$0.30
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMH
AMH
SHC
SHC
Cash + ST InvestmentsLiquidity on hand
$108.5M
$344.6M
Total DebtLower is stronger
$5.1B
$2.1B
Stockholders' EquityBook value
$7.0B
$606.0M
Total Assets
$13.2B
$3.3B
Debt / EquityLower = less leverage
0.72×
3.53×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMH
AMH
SHC
SHC
Q4 25
$108.5M
$344.6M
Q3 25
$45.6M
$299.2M
Q2 25
$323.3M
$332.4M
Q1 25
$69.7M
$304.4M
Q4 24
$199.4M
$277.2M
Q3 24
$162.5M
$306.7M
Q2 24
$718.4M
$246.1M
Q1 24
$124.8M
$261.1M
Total Debt
AMH
AMH
SHC
SHC
Q4 25
$5.1B
$2.1B
Q3 25
$4.8B
$2.1B
Q2 25
$5.2B
$2.2B
Q1 25
$4.9B
$2.2B
Q4 24
$5.0B
$2.2B
Q3 24
$4.5B
$2.2B
Q2 24
$5.0B
$2.2B
Q1 24
$4.5B
$2.2B
Stockholders' Equity
AMH
AMH
SHC
SHC
Q4 25
$7.0B
$606.0M
Q3 25
$7.2B
$550.5M
Q2 25
$7.2B
$511.3M
Q1 25
$7.2B
$414.1M
Q4 24
$7.2B
$404.9M
Q3 24
$7.0B
$470.2M
Q2 24
$7.0B
$422.8M
Q1 24
$7.0B
$429.4M
Total Assets
AMH
AMH
SHC
SHC
Q4 25
$13.2B
$3.3B
Q3 25
$13.3B
$3.2B
Q2 25
$13.6B
$3.2B
Q1 25
$13.3B
$3.1B
Q4 24
$13.4B
$3.1B
Q3 24
$12.8B
$3.1B
Q2 24
$13.3B
$3.1B
Q1 24
$12.8B
$3.1B
Debt / Equity
AMH
AMH
SHC
SHC
Q4 25
0.72×
3.53×
Q3 25
0.68×
3.89×
Q2 25
0.72×
4.34×
Q1 25
0.69×
5.36×
Q4 24
0.70×
5.49×
Q3 24
0.64×
4.73×
Q2 24
0.71×
5.26×
Q1 24
0.64×
5.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMH
AMH
SHC
SHC
Operating Cash FlowLast quarter
$864.3M
$103.1M
Free Cash FlowOCF − Capex
$823.7M
$52.4M
FCF MarginFCF / Revenue
181.0%
17.3%
Capex IntensityCapex / Revenue
8.9%
16.7%
Cash ConversionOCF / Net Profit
5.99×
2.96×
TTM Free Cash FlowTrailing 4 quarters
$1.5B
$149.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMH
AMH
SHC
SHC
Q4 25
$864.3M
$103.1M
Q3 25
$223.3M
$71.2M
Q2 25
$271.9M
$57.4M
Q1 25
$223.4M
$55.5M
Q4 24
$811.5M
$55.7M
Q3 24
$233.6M
$97.5M
Q2 24
$274.0M
$61.3M
Q1 24
$201.8M
$9.7M
Free Cash Flow
AMH
AMH
SHC
SHC
Q4 25
$823.7M
$52.4M
Q3 25
$214.5M
$35.0M
Q2 25
$257.7M
$26.2M
Q1 25
$215.9M
$35.6M
Q4 24
$777.5M
$-10.2M
Q3 24
$225.3M
$61.1M
Q2 24
$263.3M
$19.4M
Q1 24
$191.0M
$-25.2M
FCF Margin
AMH
AMH
SHC
SHC
Q4 25
181.0%
17.3%
Q3 25
44.8%
11.2%
Q2 25
56.3%
8.9%
Q1 25
47.0%
14.0%
Q4 24
178.1%
-3.5%
Q3 24
50.6%
21.4%
Q2 24
62.2%
7.0%
Q1 24
45.1%
-10.2%
Capex Intensity
AMH
AMH
SHC
SHC
Q4 25
8.9%
16.7%
Q3 25
1.8%
11.6%
Q2 25
3.1%
10.6%
Q1 25
1.6%
7.8%
Q4 24
7.8%
22.7%
Q3 24
1.9%
12.7%
Q2 24
2.5%
15.2%
Q1 24
2.6%
14.1%
Cash Conversion
AMH
AMH
SHC
SHC
Q4 25
5.99×
2.96×
Q3 25
1.91×
1.47×
Q2 25
2.20×
7.21×
Q1 25
1.74×
Q4 24
5.64×
4.52×
Q3 24
2.67×
5.73×
Q2 24
2.52×
7.00×
Q1 24
1.58×
1.53×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMH
AMH

Segment breakdown not available.

SHC
SHC

Transferred At Point In Time$198.4M65%
Nelson Labs$55.2M18%
Nordion$49.8M16%

Related Comparisons